Basic Information
Diagnoptics is a pioneer and inventor of cutting-edge diagnostic devices capable of non-invasively diagnosing and assessing the risk of diabetes and its complications. Its technological advancements in detecting advanced glycation end products (AGEs) fluorescence have led to the invention of the AGE Reader™ – an advanced diagnostic device that can determine tissue accumulation of AGEs within 30 seconds.
Diagnoptics Technologies B.V.
Groningen,Groningen,Netherlands
15~50 people
January 01, 2003
info@diagnoptics.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios